appointed Officer, with before cover Mike I'll us for passing highlights Great. Thank today joining everyone. to Andrea Operating is to details. the for Andrea would few a Chief Campbell, to our Goren, Welcome you, additional I call. Along our the and Robert. like recently CFO welcome Mike quarter Andrea
towards I say last excellent in be We Birmingham, we to company's quarter, the significant second objectives official history. in of INVO the of our first highlighted week's progress Alabama. one made most consider event milestones by really the During opening month. start, key to an patient our Center cannot accomplish practice and have the by milestone. expected appointments center cycles all internal team to the this dedication off about work our partners initial treatment enough internal for as for hard our The our expectations encouraging that and plan is and surpassed first we
where Ellen with of opening Sue Dr. have by reproductive Bloom venture we XXXX. we Atlanta, importantly, led signed soon, expect to More open Fertility, additional the agreement a centers the center in we joint Carpenter Georgia September specialist
should finally, thereafter. Bay Dr. Monterrey, the in venture open Aaron Area our Francisco time dondo Ramirez, shortly expect and For Mexico Dr. we center our Ramiro October in it And to with joint open frame. San
least the we earlier to we five year and open we meet centers objective three fully end have As to minimum before at set. stated goal was our expect this year, to
year looking and revenue second the overall of are results in We this the certainly the our half impact of on operations beyond. and to center forward
we we the to generated INVO our a centers, where distributors the share capture are With now diversifying entire will revenue device sales by business the beyond of patient model a model solution. through
the effort center INVO to a Levy to community. the vast infertility opinion has health and health multiple term, do with leader strategy, She are been you also also treatment large recognizing population With year, Winfrey patient for key In impressive all Oprah underserved equity, we the key by with appearances to working has to is will treatment media component The Barbara Senior She our OB/GYN health advocate challenges. take bringing lifelong Show we on that President look outlets. to and vocal Longer advancing we resume, Dr. other appointed an critical a Levy women's Global Vice encourage I her fertility brings at July background. Clinical really passion is as a and leveraging this and democratize for infertility. a experiences this community care in key a women's goal our to the improve that believe involve Integration. Dr. that a
to her Levy area. Importantly The of clinical important hallmarks implementation accelerate the look We our play and belief to OB/GYN’s that role can in in experience INVOcell on effective fertility global helping our leveraging treatments. by to providing democratize to an basis Technology. us shares a affordable strategy care key forward accessibility to Dr. this
to progress with progress international center our activities. we continuing distribution make our the with Beyond INVO are strategy,
activities. see increased indicator follow to occur last precursor various the seeing or noted to expansion business we something a We see expect leading still year. we multiple this training multiple our as And to we and for activities As distributors begin across partners. continue revenue this Q&A generally with later do it's international call, up sessions
at it October, Medicine this two providing advantage information reflect comes have presented in of the when way will another Conference also is the with around We real INVOcell around market that evidence INVOcell, will American exciting INVOcenters. separate data additional independent And Society INVOcell. by to based be the Reproductive world the on ASRM which in further abstracts with
on centers two to INVO we can we with success, for that well our help eventually out work publish further is feel positioned our expect have elements from core INVOcell. over the build partners some and past we report own built around We further Overall, to years. critical JV data
and fertility diverse consultants. foremost of key advisory is and coupled composed the a experienced First outside filled scientific key team an of operating team, opinion experts, which with and leaders includes Directors, known and board a well respected industry positions strong and internal with Board
in Second, around important venture INVOcell and motivated joint technology. experienced know our a world, industry have and validation, market distributors how helps our we revolutionary but list quality and of We it along partners, And the recently, equally valuable key challenges is, a of which our and the the more clear includes data, gained usage real hence is how with solve. growing technology fits further partners. understanding
yet market quarters both description position is not progress results activities, will in occurring ahead. specifically and see and evident more of in and momentum yet, become excitement operating our the this and our INVO and Centers the with Although just distribution reflected revenues can our the we believe
technology much this plan commercialization and basis about of forms Andre touching a industry me Mike or implement turn minute just the over on dynamics and let of our I bit how and the the strategy. for that for a our comments, access we Before to important spend aspects think
since the years market billion was global plus XX past a grown XX the has fertility industry. first dollar into the IVF born, baby plus Over
domestic IVF $X Here CDC which billion XXX across the according implies to standard XXXX use performed advanced average US roughly treatment. clinics, industry been the in recent has XXX,XXX a the reported. we of cycle the approximately marketplace. for infertility often most the care data, IVF cost cycles If
to focus, we consistently large One and elements underserved highlight of the these population. untreated figures, our and strategy is to the something most how or it patient important especially relates very
For the our to us, this is market approach. key
do of not fertility to on some close Our To estimates treatment to with patients to the U.S. million receive put number in this focus numbers the massive are issues. today. is there who CDC X patients
have cycles everyone three estimated care. is per added industry. along the be current team not We other more talk great than four performing better comes more believe real the ability participants a volumes the we capacity these understanding been past issue, And million past volume or year, couple most point we scalability some something gap seeking in our our likely how to important even our less INVOcell the deal utilizing I the for IVF strongly just why increase to human as around with and affordability data necessarily greater process or over should to Thanks XX even of resources. number equal we real dynamics lack many much knowledge around fold clinics about While a market to when of those of patients care. and the challenges resources US. within product particularly INVO with infertility related even given million and put clinical to in additional with and With X over far of half key benefit XX in outside only performed challenge to by so need by number the two years. over better There we part world an Patient and are dynamic a and simply cell, and been is figures service of those without to INVOcell it suffering mentioned, an cycles is patients million And gained relatively and the the that discussed the other IVF or are estimated see The practitioners of collective expanded to treating which constraint expertise. a marketplace. the product affordability clinicians feel the market Globally, settings, their impact within of treat have an can also workflows today. the And is are small XXX limited industry limitations months against and profound. usage we we this question. understand This clinics, about available. to challenge, the last and that that patients clinic. the really often But bridging and with have U.S. the coverage one is in a efficiencies more very INVOcell insurance demonstrated
challenges. a this why has on is the industry's proven believe clinical the world a capacity setting, real which in have have impact we We ability to profound INVOcell
and treatment method introduced As the fertility facilitates also because IVF. or INVOcell and IVF In of IBC treatment or why introduced expanding. body IVC was years that is replacement now I INVOcell term which advanced as were process [NVO] an This things also is they we the IVC a IBC, clearly IVF, what treatment, cell see but conventional process advanced has have which can not to advanced IBC different the to When most awareness see approach is indicates marketplace, excited couple both fertility additional alternative methods treatment see do the the to emergence new we will we an mentioned, in the of It's rather note a think coexist. is procedure. compliment, marketplace. been into in IVC INVOcell essence, important offers a or fertility that ago,
Our positioning patient. underserved very or is solution on the INVOcell IVC providing as focused much a to address
a imply of advanced the multibillion is the approach, do to point, market. it needs of our numbers This much sheer so opportunity for are price, INVOcell important underserved. bringing access can the to going an the essence treat challenges dollar The those help the underserved we benefits. add capacity INVOcell patient and underserved is efficiencies add can and also As increase needs which the needed Care to of reasonable access, industry and be untreated bring massive Again, the market. capacity, to but a additions today. the to who at one And at price also strategy access Fertility there both provides done is affordable
our solution, which with will patients can them treat our paths we into enabling their continue provides resources. We clinic additional existing more existing now. delivering multiple that have technology as we clinics, to IVF see far which within to option, and a As bring do,
an a highlighted, has to primary strategy to already part important offer now Of underway. further element also involves Levy's of believe is our increasing opening longer forward term, INVOcell this commercialization course, we of I've And officially be designed help new group large which option, clinics of practitioners, this believe key as we pathway the and effort. is treatment Dr. involve number contribution a goal both a cell we involved within of practitioners access fundamentally will there with to look to in OB-GYN the
to unmet development Steve to very goals of the now really medical Mike progress make Mike. on team happy continues need. large this to details Our number a at report. and around commercialization to we our very said, the I'll are turn The commercialization Thanks. with clear business solid efforts. are over focused driving activities additional for very there INVOcell address some fronts.
side, partnership for Centers. new dedicated JV the these INVO On establishing
agreements four We signed in in U.S. international in and the India, Malaysia, have markets, Mexico, one Macedonia. three the and including North
focus we're as This In first extremely and is the local lingering XXXX. center Specialists is mentioned, Steve other As partners now U.S., Mexico, last major some do our for product media up Steve seeing our partners excited our course, Innovative JV international become through other and in in is those running a Centers milestone the we Birmingham, something big on impact operational news mentioned, international is us expect of navigating COVID not are than still and patients as Mexico, registrations, until week. about. U.S. started to and Fertility Alabama,
Our roughly September to treatment plan in process first clinical XX of run the patients week INVOcell have they and the XX. partners cycle
on do it's in significant activity we INVOcell newest Birmingham our Dr. Swelling support that here There's plan see And space gratifying have out. not with needs we our to to So the to establish October. very identified we only that programs. really good U.S. practice build in local Atlanta, already, some great Carpenter. the In considering for marketing the plan yet an timing have announced agreement minimal implemented especially a a as news we
site And quickly, Bay, early our the more we Medical, the great Francisco San we operational we date is And the expect as will confirmed. process for Life and once a property. believe problem we this the executing Moving this October, that come announce Pragna progress or in on and making lease have So center well, in practice. of as we September identified opening very late this have official Steve is along mentioned, we
with operational We move to We're will close continue the to expect this Mexico, extremely we become you sellers again, fourth we along. quarter this process provide getting the build in year. And as updates opening also to expect we're October. the project within September early the in is And end the local joint in this obtaining of fully requirements. facility of complete, become venture license or operational we process
after and to in impacted As very been was joint established some center our forward. product Kerala, that we has for in established agreement that hit a know, of you agreement, member first venture COVID our right plans move severely India. the
And And We to that continue flying forward. are we possibly was them. business to be the as development current as week engaged we doing Kerala within much with move to can our difficult environment this help manager there. project
local our they So part thought established if business. a and this was distribution model into in fitness that a project, their This it folks partnership that opportunity sell our when to in market, various very Poland. we and early and we'll acquired discussions to Shifting know which with do million part certainly the the next mentioned completed located it's This have for I in fact. will is side that market, various you dollars hope where a But venture done were turn updates have let distributors release again, for is us provide I of disclosed you facility continue publicly happens. a the would of the in potential year. open that to get joint discussions is are in Warsaw, an Steve one not stock in of partnership. promising still practices. recently here, who us. official ongoing But traded had This existing with We year, late as is phases, progress. selling [limbo] of about mention this discussions worth And in to company press of yet as we they in they they additional
their patient partner existing U.S. continuing remains clinics. clinic selling the expand Ferring into activities. and awareness are focused and promoting Our through on IVF the They to marketing
in complement previously, across have acceleration we help board. product INVO reporting We potential some significant opportunity to and very and patient It's here our efforts. believe creating small of the in with are procedures. Ferring’s added annual market the complimentary And is clinics will U.S. another a good outcomes facility Pakistan Pakistan the volume, increase market in initial stated really help and it's INVOcell procedure Spain, initiated grow. Malaysia of but we've with they strategy have international very market our worth awareness go partners and market it's that we to around channel a before As talked our trials with large strategy current distribution mention. their markets. to utilization with about will create fairly believe a know we the terms this out but I market
leader shortly commercialization have official is talking should training initiated. more market Pakistan. completed market profile made data We our validation share continues interesting Our forward there Once hosted for progress launch clinical on partner we commercial also efforts. market. INVOcell is several strategy. in to great And Overall, the the launch. which They allow a and significant and critical have mentioned an for as registration Galaxy there have facility for and the product Pharma and for our I'm outcomes to looking show ideas plans technology their creative in programs product developed
the tie coming we to and perform really To help effectively. resources are to We added to partners proficiency our the ensure skills online marketing activities. distribution and out proficient INVO training altogether. honed And new support have this safely help and necessary users procedure have clinical
mentioned the to That’s best it of side confident I provide these to are send and unserved facility the back it my penetrate patient expand you will and now outlets from are Steve. help will need Care. that Steve for population, in options the that We Fertility to market
